CARBOCAINE 3% DIN 02474174
Health Canada record
| Active ingredient(s) | MEPIVACAINE HYDROCHLORIDE 30 MG |
|---|---|
| Dosage form | Solution |
| Route | Block/Infiltration |
| Schedule | ETHICAL |
| Class | Human |
| ATC | N01BB03 MEPIVACAINE |
| Original market date | 07-May-2019 |
| Current status date | 07-May-2019 |
| Source | Health Canada DPD |
Establishment licence of the holder
Septodont Ou Septodont S.A.S. Ou Specialites Septodont — licence , not currently licensed, last inspection rating C (2023-05-25).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MEPIVACAINE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02330733 | 3% POLOCAINE DENTAL | DENTSPLY CANADA LIMITED | Liquid | MEPIVACAINE HYDROCHLORIDE 30 MG | Marketed |
| 02241999 | CARBOCAINE 1% | PFIZER CANADA ULC | Solution | MEPIVACAINE HYDROCHLORIDE 10 MG | Marketed |
| 02242000 | CARBOCAINE 1% | PFIZER CANADA ULC | Solution | MEPIVACAINE HYDROCHLORIDE 10 MG | Marketed |
| 02242001 | CARBOCAINE 2% | PFIZER CANADA ULC | Solution | MEPIVACAINE HYDROCHLORIDE 20 MG | Marketed |
| 00364304 | ISOCAINE HCL INJ 3% | NOVOCOL PHARMACEUTICAL OF CANADA INC | Solution | MEPIVACAINE HYDROCHLORIDE 30 MG | Marketed |
| 00479934 | SCANDONEST 3% PLAIN INJ | SEPTODONT | Solution | MEPIVACAINE HYDROCHLORIDE 30 MG | Marketed |
| 00874639 | 2% POLOCAINE DENTAL WITH LEVONORDEFRIN 1:20,000 | DENTSPLY CANADA LIMITED | Solution | MEPIVACAINE HYDROCHLORIDE 20 MG; CORBADRINE 0.05 MG | Cancelled Post Market |
| 02026953 | CARBOCAINE LIQ 2% | SANOFI CANADA, INC. | Liquid | MEPIVACAINE HYDROCHLORIDE 20 MG | Cancelled Post Market |
| 01985086 | CARBOCAINE 2% NEO-COBEFRIN 1:20,000 LIQ | KODAK CANADA INC. | Liquid | MEPIVACAINE HYDROCHLORIDE 20 MG; CORBADRINE HYDROCHLORIDE .05 MG | Cancelled Post Market |
| 02474182 | CARBOCAINE 2% WITH NEO-COBEFRIN | NOVOCOL PHARMACEUTICAL OF CANADA INC | Solution | MEPIVACAINE HYDROCHLORIDE 20 MG; CORBADRINE 0.05 MG | Cancelled Post Market |
| 02263580 | CARBOCAINE 2% WITH NEO-COBEFRIN | KODAK CANADA INC. | Solution | MEPIVACAINE HYDROCHLORIDE 20 MG; CORBADRINE 0.05 MG | Cancelled Post Market |
| 02281414 | CARBOCAINE 2% WITH NEO-COBEFRIN | CARESTREAM HEALTH CANADA COMPANY | Solution | MEPIVACAINE HYDROCHLORIDE 20 MG; CORBADRINE 0.05 MG | Cancelled Post Market |
| 02271796 | CARBOCAINE 3% | CARESTREAM HEALTH CANADA COMPANY | Solution | MEPIVACAINE HYDROCHLORIDE 30 MG | Cancelled Post Market |
| 01985078 | CARBOCAINE 3% | KODAK CANADA INC. | Solution | MEPIVACAINE HYDROCHLORIDE 30 MG | Cancelled Post Market |
| 01959891 | CARBOCAINE INJ LIQ 10MG/ML | STERLING WINTHROP INC. | Liquid | MEPIVACAINE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 01959913 | CARBOCAINE INJ LIQ 20MG/ML | STERLING WINTHROP INC. | Liquid | MEPIVACAINE HYDROCHLORIDE 20 MG | Cancelled Post Market |
| 02017571 | CARBOCAINE LIQ 1% | SANOFI CANADA, INC. | Liquid | MEPIVACAINE HYDROCHLORIDE 1 % | Cancelled Post Market |
| 02017563 | CARBOCAINE LIQ 1% | SANOFI CANADA, INC. | Liquid | MEPIVACAINE HYDROCHLORIDE 1 % | Cancelled Post Market |
| 01910043 | EQUICAINE | ZOETIS CANADA INC | Solution | MEPIVACAINE HYDROCHLORIDE 20 MG | Dormant |
| 00393711 | ISOCAINE HCL INJ 2% | NOVOCOL PHARMACEUTICAL OF CANADA INC | Solution | MEPIVACAINE HYDROCHLORIDE 20 MG; CORBADRINE 0.05 MG | Cancelled Post Market |
| 00753130 | MEPIVICAINE HYDROCHLORIDE INJECTION, USP 3% | DENTSPLY CANADA LIMITED | Solution | MEPIVACAINE HYDROCHLORIDE 30 MG | Cancelled Post Market |
| 00479942 | SCANDONEST 2% SPECIAL INJ | SEPTODONT | Liquid | MEPIVACAINE HYDROCHLORIDE 20 MG; EPINEPHRINE 0.01 MG | Dormant |
| 02313863 | SCANDONEST 2% WITH LEVONORDEFRIN | NOVOCOL PHARMACEUTICAL OF CANADA INC | Solution | MEPIVACAINE HYDROCHLORIDE 20 MG; CORBADRINE (CORBADRINE HYDROCHLORIDE) 0.05 MG | Cancelled Post Market |
International API supply for MEPIVACAINE HYDROCHLORIDE
4 valid EDQM Certificates of Suitability from 4 holders. 2 active FDA Drug Master Files.
Request a quote for CARBOCAINE 3%